Healthcare Sales & Marketing Network News: NNR Therapeutics

Searching News Database: NNR Therapeutics

HSMN NewsFeed - 8 Jan 2014
Targacept Appoints John P. Richard as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 Mar 2012
AstraZeneca and Targacept Announce Remaining TC-5214 Phase 3 Efficacy Studies Do Not Meet Primary Endpoint, Regulatory Filing Will Not Be Pursued
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Biopharmaceuticals

HSMN NewsFeed - 27 Dec 2006
Targacept to Receive $20 Million Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480 (TC-1734)
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Nov 2006
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2006
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
Biopharmaceuticals Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.